-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on PROCEPT BioRobotics, Raises Price Target to $21

Benzinga·11/06/2026 00:44:26
Listen to the news
UBS analyst Patrick Wood maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutral and raises the price target from $20 to $21.